20 Sep 2012 14:59
Silence Therapeutics Notice of Results
London, UK, 20 September 2012 -Silence Therapeutics plc (AIM: SLN), a leading global RNA interference therapeutics company, will issue its interim financial results for the six months ended 30 June 2012 on Tuesday, 25 September 2012.
--Ends--
For further information, please contact:
Silence Therapeutics Ali Mortazavi +44 7768 694739
a.mortazavi@silence-therapeutics.com
Jerry Randall +44 7990 502000
j.randall@silence-therapeutics.com
Singer Capital Markets M:Communications Shaun Dobson/Jenny Wyllie Mary-Jane Elliot / Sarah MacLeod / +44 20 32057500 Claire Dickinson shaun.dobson@singercm.com +44 20 7920 2342 jenny.wyllie@singercm.com silencetherapeutics@mcomgroup.com
XLON